Delivery Order SPE2D020D0009-SPE2D325F0807

Award Date 10/23/24
Potential Completion Date 10/28/24
Potential Value $42K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award, valued at $78,482.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4,561,244,124 vials of vancomycin, a critical antibiotic medication, with a performance period ending on June 6, 2023. This contract is not set aside for any specific business type. Fresenius Kabi, LLC is a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The award, valued at $5,773.18, is a delivery order contract for the supply of 4566185315 vials of Vancomycin 1 gram, a critical care antibiotic. The contract has a firm fixed price pricing type and an ultimate completion date of October 28, 2024. Fresenius Kabi, LLC is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $12,220.60 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with an ultimate completion date of October 28, 2024. Fresenius Kabi is a major supplier of critical care pharmaceuticals, including injectable medications, infusion...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $3,286.92 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with a period of performance through October 28, 2024. The contract has no set-aside designation. Fresenius Kabi is a significant supplier of injectable medications...
This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price...
This federal contract award is a delivery order (SPE2D020D0009|SPE2D325F0869) from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency, to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The $369,567.80 firm-fixed-price contract is for the delivery of 4,566,196,941 units of the antibiotic drug vancomycin in 1 gram vials. The contract has an ultimate completion date of October 29, 2024 and does not have a set-aside...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule contract, awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, a critical antibiotic medication. The award has a ceiling value of $204,603.28 and a period of performance ending on March 31, 2016. This contract does...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F0807
    Delivery Order

This federal contract award, valued at $42,434.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a Firm Fixed Price Delivery Order for the supply of Vancomycin 1 GM Vials, a critical care injectable medication, with a performance period extending through October 28, 2024.

Fresenius Kabi is a significant supplier of injectable medications, infusion therapies, and medical solutions to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a substantial Indefinite Delivery Contract (IDC) valued at $2.24 million with the VA National Acquisition Center for the supply of bortezomib, a cancer treatment drug. This IDC supports pharmaceutical requirements across multiple federal agencies, including the VA, DoD, Bureau of Prisons, and Indian Health Service.

Generated 1/22/25, 9:29 AM